venBio Global Strategic Fund II L.P., 10% Owner at Checkmate Pharmaceuticals, Inc. (CMPI), sold 155,754 shares at $10.37 ($1.6M) on 2022-05-05, disclosed to the SEC on 2022-05-09.
Open-market sale of $1.6M CMPI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.37 | 20,743 | $215K | 13.3% |
| 2 | $10.37 | 20,743 | $215K | 13.3% |
| 3 | $10.37 | 48,334 | $501K | 31.0% |
| 4 | $10.37 | 48,334 | $501K | 31.0% |
| 5 | $10.37 | 17,600 | $183K | 11.3% |
| Total | $10.37 avg | 155,754 |
| $1.6M |
| 100% |
| Filing → |
| IMPL | BUY | 2021-04-29 | $6.8M | — | Filing → |
| AKRO | SELL | 2020-07-06 | $8.0M | — | Filing → |
| AKRO | SELL | 2020-02-10 | $330K | — | Filing → |